| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
T2 Biosystems, Inc. (TTOO) has 0 insiders with recent SEC Form 4 filings, including 5 buys and 7 sells. TTOO is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Gibbs Michael Terrence | General Counsel | Sale+OE | 3,730 | $0.62 | $2,329.40 | -24.2% | |
| Feb 28, 2023 | Sperzel John J III | Chairman And CEO | Sale+OE | 9,773 | $0.63 | $6,178.57 | -24.0% | |
| Feb 22, 2023 | Giffin Brett A. | Chief Commercial Officer | Sale+OE | 537 | $0.65 | $349.05 | -39.0% | |
| Nov 10, 2022 | Giffin Brett A. | Chief Commercial Officer | Sale+OE | 1,292 | $1.79 | $2,316.56 | -36.4% | |
| Apr 8, 2022 | Barclay Alec | Chief Operations Officer | Buy | 12,952 | $0.50 | $6,475.94 | +7.7% | |
| Apr 8, 2022 | Sprague John M | Chief Financial Officer | Buy | 10,000 | $0.48 | $4,767.00 | +7.0% | |
| Apr 8, 2022 | Giffin Brett A. | Chief Commercial Officer | Buy | 10,600 | $0.49 | $5,183.40 | New | |
| Apr 7, 2022 | Sperzel John J III | Chairman, CEO, And President | Buy | 30,000 | $0.50 | $15,000.00 | +15.6% | |
| Apr 7, 2022 | Gibbs Michael Terrence | General Counsel | Buy | 10,000 | $0.49 | $4,900.00 | +6.4% | |
| Jan 6, 2022 | Ahuja Aparna | Chief Medical Officer | Sell | 61,988 | $0.48 | $29,754.24 | -36.5% |